You are here: Industry Insights > Insilico

News List

The Former Director of the Center for Drug Evaluation and Research at FDA and R&D Leader at Amgen, Steven Galson Joins Insilico Medicine as Independent Director prnasia
August 12, 2021
Insilico Medicine, a global leader in end-to-end AI-powered drug discovery, announced the appointment of Steven Galson, MD, MPH as the independent member of the board of directors.
Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine prnasia
August 05, 2021
Insilico Medicine announced that its AI-powered drug discovery platform had delivered the preclinical candidate ("PCC") for kidney fibrosis.
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI prnasia
August 05, 2021
Insilico Medicine, an industry leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, and Usynova announced to reach strategic cooperation in advancing the development of novel therapies.
Insilico Medicine and Westlake Pharma Announce Cooperation Relationship on Accelerating the Innovative Drugs R&D for Novel Coronavirus prnasia
August 03, 2021
Insilico Medicine and Westlake Pharma announced a strategic partnership to jointly develop innovative small-molecule drugs for Novel Coronavirus (COVID-19) today.
GenFleet Therapeutics and Insilico Medicine Announce Strategic Partnership prnasia
July 21, 2021
GenFleet Therapeutics and Insilico Medicine announced to reach strategic partnership in advancing development of novel therapies today.
Insilico enters into a collaboration with APRINOIA to apply novel generative AI-powered system to discover novel compounds for neurodegenerative diseases prnasia
December 30, 2020
Insilico Medicine is pleased to announce that it has entered into a research collaboration with APRINOIA Therapeutics to utilize Insilico's novel generative artificial intelligence (AI) technology to accelerate the discovery of next generation ...
Insilico and Boehringer to use AI for drug targets discovery pharmaceutical-technology
April 16, 2020
Boehringer partners Insilico for AI-based discovery of drug targets. Insilico Medicine has partnered with Boehringer Ingelheim.
Insilico Opens Subsidiary in Boston contractpharma
March 03, 2020
The Boston subsidiary´s prime location is within the largest biopharmaceutical hub in the US.
Insilico Medicine develops new AI drug discovery system pharmaceutical-technology
September 04, 2019
Insilico Medicine has developed an artificial intelligence (AI)-powered system to facilitate the creation of therapeutic molecules.
Insilico, ARK initiate health-span and longevity partnership pharmatimes
May 28, 2019
Insilico Medicine has announced the beginning of a partnership with Ageing Research at King’s (ARK), a new world-class multi-disciplinary center for ageing research formed at King's College London.

Previous page 1 2 Next page